-
公开(公告)号:US11535670B2
公开(公告)日:2022-12-27
申请号:US16541020
申请日:2019-08-14
IPC分类号: A61K39/00 , C07K16/28 , A61P35/00 , A61K45/06 , A61K31/4406 , A61K39/395
摘要: Provided herein are combinations that include an HDACi and a PD-L1 inhibitor that are useful for treating cancer, including cancer resistant to PD-1 inhibitors.
-
公开(公告)号:US12122833B2
公开(公告)日:2024-10-22
申请号:US16541007
申请日:2019-08-14
IPC分类号: A61K39/00 , A61K31/167 , A61K31/18 , A61K31/343 , A61K31/395 , A61K31/4045 , A61K31/4184 , A61K31/4406 , A61K31/506 , A61K38/15 , A61K39/395 , A61K45/06 , C07K16/28
CPC分类号: C07K16/2818 , A61K31/167 , A61K31/18 , A61K31/343 , A61K31/395 , A61K31/4045 , A61K31/4184 , A61K31/4406 , A61K31/506 , A61K38/15 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , A61K2039/545 , C07K2317/76 , A61K31/167 , A61K2300/00 , A61K31/18 , A61K2300/00 , A61K31/343 , A61K2300/00 , A61K31/395 , A61K2300/00 , A61K31/4045 , A61K2300/00 , A61K31/4184 , A61K2300/00 , A61K31/4406 , A61K2300/00 , A61K31/506 , A61K2300/00 , A61K38/15 , A61K2300/00 , A61K39/39541 , A61K2300/00
摘要: Provided herein are combinations that include an HDACi and a PD-1 inhibitor that are useful for treating cancer, including reducing and/or preventing cancer metastasis. The combination is also useful for treating cancer that has been previously treated with a PD-L1 inhibitor.
-